Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Nephrogen |
Description | We’re building curative gene therapies for life threatening kidney Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease |
Keywords | N/A |
WebSite | nephrogenbiotech.com |
Host IP | 99.83.190.102 |
Location | United States |
Site | Rank |
US$578,695
Last updated: 2023-05-16 12:56:00
nephrogenbiotech.com has Semrush global rank of 18,289,955. nephrogenbiotech.com has an estimated worth of US$ 578,695, based on its estimated Ads revenue. nephrogenbiotech.com receives approximately 66,773 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, nephrogenbiotech.com is safe to visit. |
Purchase/Sale Value | US$578,695 |
Daily Ads Revenue | US$535 |
Monthly Ads Revenue | US$16,026 |
Yearly Ads Revenue | US$192,305 |
Daily Unique Visitors | 4,452 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nephrogenbiotech.com. | A | 3599 | IP: 99.83.190.102 |
nephrogenbiotech.com. | A | 3599 | IP: 75.2.70.75 |
nephrogenbiotech.com. | NS | 3600 | NS Record: ns41.domaincontrol.com. |
nephrogenbiotech.com. | NS | 3600 | NS Record: ns42.domaincontrol.com. |
nephrogenbiotech.com. | MX | 3600 | MX Record: 0 nephrogenbiotech-com.mail.protection.outlook.com. |
nephrogenbiotech.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
ABOUT Technology Team News Contact We’re building curative gene therapies for life threatening kidney diseases. Launch your product — and savor the momentum. Get the App research and advisors from OUR MISSION Nephrogen is a seed-stage biotech company developing curative gene therapies for kidney diseases . Our initial indication is autosomal dominant polycystic kidney disease (ADPKD), which affects 600,000 Americans and has no cure or effective treatment. Tolvaptan (JYNARQUE®) is the only FDA approved drug for ADPKD, costs $13K for a 28-day supply, and must be taken twice daily for decades for maximum benefit. Our solution aims to halt ADPKD from the onset and provide an outright cure for the disease. We’re boldly committed to reimagining therapeutics for life threatening kidney disease. Our broad patent portfolio will allow us to rapidly translate our technologies into foundational partnerships and transformative treatments. Our technology Curative gene therapies for kidney diseases. |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Wed, 26 Jan 2022 12:28:13 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://nephrogenbiotech.com/ HTTP/2 301 server: openresty date: Wed, 26 Jan 2022 12:28:14 GMT content-type: text/html content-length: 166 location: https://www.nephrogenbiotech.com/ HTTP/2 200 server: openresty date: Wed, 26 Jan 2022 12:28:14 GMT content-type: text/html content-length: 28121 x-lambda-id: 28b0a7ad-9d67-42c3-82b0-12e3394e15ab via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 17708 x-served-by: cache-iad-kiad7000103-IAD, cache-dub4351-DUB x-cache: HIT, HIT x-cache-hits: 1, 1 x-timer: S1643200095.633218,VS0,VE3 vary: Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
Domain Name: NEPHROGENBIOTECH.COM Registry Domain ID: 1979172657_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-09-23T16:32:50Z Creation Date: 2015-11-13T05:30:59Z Registry Expiry Date: 2022-11-13T05:30:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS41.DOMAINCONTROL.COM Name Server: NS42.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-26T07:56:21Z <<< |